Company / Book Value per Share
Editas Medicine, Inc. Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.623
FY2025
5-year range
$1.623 / $8.042
FY2021-FY2025
Trend
-62.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 8 years, ranging from $1.623 in FY2025 to $8.042 in FY2023.
Based on SEC 10-K filings.
$1.623 in FY2025 with a 5-year CAGR of -17.9%.
Declined from $8.042 to $1.623 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -34.4%
- 5-Year CAGR
- -17.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -17.9%, indicating a declining trend.
- In FY2025, book value per share decreased 62.0% year-over-year.
- Peak book value per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.623 | -62.0% |
| FY2024 | $4.269 | -46.9% |
| FY2023 | $8.042 | +39.8% |
| FY2022 | $5.751 | +37.1% |
| FY2021 | $4.195 | -3.5% |
| FY2020 | $4.345 | +1.8% |
| FY2019 | $4.268 | +41.1% |
| FY2018 | $3.024 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026